Nara, Japan

Gyoonhee Han

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gyoonhee Han. Retrieved from https://idiyas.com/inventor/gyoonhee-han-t44t4uk6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gyoonhee Han: Innovator in Sulfur-Containing Analog Research

Introduction

Gyoonhee Han is a prominent inventor based in Nara, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that exhibit promising pharmacological properties.

Latest Patents

Han holds a patent for "Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3." This innovative work presents sulfur-containing analogs of 1α,25-dihydroxy vitamin D that are synthesized through a convergent approach by joining A-ring and C,D ring fragments. Each analog, characterized by 1α,3β-substituent stereochemistry, demonstrates a desirable combination of high antiproliferative and transcriptional activities in vitro, along with low calcemic activity in vivo. He has 1 patent to his name.

Career Highlights

Gyoonhee Han is affiliated with The Johns Hopkins University, where he continues to advance research in his field. His work has garnered attention for its potential applications in therapeutic settings.

Collaborations

Han has collaborated with notable colleagues, including Gary H. Posner and Jae-Kyoo Lee, contributing to the advancement of research in medicinal chemistry.

Conclusion

Gyoonhee Han's innovative research in sulfur-containing analogs showcases his commitment to developing compounds with significant therapeutic potential. His contributions to the field are noteworthy and continue to influence future research directions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…